InsiderTrades

Form 4 for ALNY ALNYLAM PHARMACEUTICALS, INC.

Accepted 2024-06-26 00:00:00 ET · period of report 2024-06-24 · accession 0001735276-24-000070 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2024-06-26 2024-06-24 ALNY PYOTT DAVID E I Dir M - OptEx $80.76 +32.5K 32.6K +23,860% +$2.62M
DM 2024-06-26 2024-06-24 ALNY PYOTT DAVID E I Dir S - Sale+OE $220.69 -32.5K 7,606 -81% -$7.16M
DM 2024-06-26 2024-06-24 ALNY PYOTT DAVID E I Dir M - OptEx $0.00 -32.5K 3,830 -89% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-06-24 M A 7,420 $70.20 25,116 D — —
2 Common Common Stock 2024-06-24 S D 7,470 $222.00 136 D — —
3 Common Common Stock 2024-06-24 S D 17,560 $220.00 15,026 D — —
4 Common Common Stock 2024-06-24 S D 7,420 $221.00 7,606 D — —
5 Common Common Stock 2024-06-24 M A 17,560 $88.95 17,696 D — —
6 Common Common Stock 2024-06-24 M A 7,470 $71.99 32,586 D — —
7 Derivative Stock Option (right to buy) 2024-06-24 M D 17,560 $0.00 7,440 D $88.95 · — to 2025-12-18 17,560 Common Stock (F5) This stock option was fully vested and exercisable as of December 18, 2018.
8 Derivative Stock Option (right to buy) 2024-06-24 M D 7,470 $0.00 3,780 D $71.99 · 2018-06-02 to 2027-06-01 7,470 Common Stock (F4) This stock option was fully vested and exercisable as of June 2, 2018.
9 Derivative Stock Option (right to buy) 2024-06-24 M D 7,420 $0.00 3,830 D $70.20 · 2017-06-03 to 2026-06-03 7,420 Common Stock (F3) This stock option was fully vested and exercisable as of June 3, 2017.